1 |
10-mg dose of e5501 2g tablet |
- |
- |
- |
- |
063 [1] 63 💬 |
2 |
10-mg dose of e5501 cyclodextrin oral solution |
- |
- |
- |
- |
063 [1] 63 💬 |
3 |
10-mg dose of e5501 lipid-based oral |
- |
- |
- |
- |
063 [1] 63 💬 |
4 |
10-mg dose of e5501-p21% powder |
- |
- |
- |
- |
063 [1] 63 💬 |
5 |
[ucb7665 ] |
- |
- |
- |
- |
063 [1] 63 💬 |
6 |
Akr-501, ym-477 |
- |
- |
- |
- |
063 [1] 63 💬 |
7 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
8 |
Alemtuzumab, rituximab |
Alemtuzumab |
[2] D02802 D02802, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
9 |
All-trans retinoid acid(atra) |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
063 [1] 63 💬 |
10 |
Amg 531 |
- |
- |
- |
- |
063 [1] 63 💬 |
11 |
Amg531 |
- |
- |
- |
- |
060 [2] 60, 63 💬 |
12 |
Aminophylline |
Aminophylline |
[2] D00227 D00227, D05429 D05429 💬 |
ADORA1 [18] ADORA1, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
Alcoholism [23] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
063 [1] 63 💬 |
13 |
Amoxicillin |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 [7] 6 , 46, 63, 96, 97, 222, 299 💬 |
14 |
Amoxicillin hydrate |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
063 [1] 63 💬 |
15 |
Amoxycillin |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
063 [1] 63 💬 |
16 |
Anti-cd40l |
Toralizumab |
[1] D06193 D06193 💬 |
CD40LG [1] CD40LG 💬 |
Allograft rejection [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis |
063 [1] 63 💬 |
17 |
Anti-cd40ldab |
- |
- |
- |
- |
063 [1] 63 💬 |
18 |
Anti-d |
- |
- |
- |
- |
063 [1] 63 💬 |
19 |
Argx-113 |
- |
- |
- |
- |
011 [4] 11, 14, 35, 63 💬 |
20 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
21 |
Atorvastatin 10mg |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 [1] 63 💬 |
22 |
Atorvastatin 20mg |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 [1] 63 💬 |
23 |
Atra |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
063 [2] 63, 94 💬 |
24 |
Avatrombopag |
Avatrombopag |
[1] D10306 D10306 💬 |
- |
- |
063 [1] 63 💬 |
25 |
Avatrombopag (proposed) |
Avatrombopag |
[1] D10306 D10306 💬 |
- |
- |
063 [1] 63 💬 |
26 |
Avatrombopag maleate |
Avatrombopag |
[1] D10306 D10306 💬 |
- |
- |
063 [1] 63 💬 |
27 |
Avatrombopag tablets |
Avatrombopag |
[1] D10306 D10306 💬 |
- |
- |
063 [1] 63 💬 |
28 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
29 |
Blinded (avatrombopoag tablets) |
- |
- |
- |
- |
063 [1] 63 💬 |
30 |
Blisibimod |
Blisibimod |
[1] D10311 D10311 💬 |
- |
- |
043 [5] 43, 44, 49, 63, 66 💬 |
31 |
Bms-986004 |
- |
- |
- |
- |
063 [1] 63 💬 |
32 |
Bms-986004 1500 mg iv |
- |
- |
- |
- |
063 [1] 63 💬 |
33 |
Bms-986004 225 mg iv |
- |
- |
- |
- |
063 [1] 63 💬 |
34 |
Bms-986004 675 mg iv |
- |
- |
- |
- |
063 [1] 63 💬 |
35 |
Bms-986004 75 mg iv |
- |
- |
- |
- |
063 [1] 63 💬 |
36 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
37 |
Bt595 |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
38 |
Caffeic acid tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
39 |
Clarithromycin |
Clarithromycin |
[1] D00276 D00276 💬 |
- |
- |
006 [8] 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
40 |
Conventional |
- |
- |
- |
- |
063 [1] 63 💬 |
41 |
Corticosteroids (aprednislon) |
- |
- |
- |
- |
063 [1] 63 💬 |
42 |
Csa |
- |
- |
- |
- |
019 [8] 19, 49, 50, 53, 60, 63, 222, 228 💬 |
43 |
Cyclosporin |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 [17] 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
44 |
Cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [11] 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
45 |
Cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [35] 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
46 |
Danazol |
Danazol |
[1] D00289 D00289 💬 |
AR [3] AR, ESR1, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
060 [5] 60, 63, 64, 65, 285 💬 |
47 |
Daratumumab |
Daratumumab |
[1] D10777 D10777 💬 |
CD38 [1] CD38 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
016 [4] 16, 28, 63, 222 💬 |
48 |
Decitabine |
Decitabine |
[1] D03665 D03665 💬 |
DNMT1 [3] DNMT1, DNMT3A, DNMT3B 💬 |
Cysteine and methionine metabolism [3] Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer |
063 [1] 63 💬 |
49 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
50 |
Dexamethasone (1 cycle) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
51 |
Dexamethasone (4 cycles) |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
52 |
Dexamethasone abcur |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
53 |
Dexamethasone and rituximab |
Dexamethasone |
[10] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
54 |
Doptelet |
- |
- |
- |
- |
063 [1] 63 💬 |
55 |
Doptelet 20 mg film-coated tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
56 |
Doxil |
- |
- |
- |
- |
063 [1] 63 💬 |
57 |
E5501 |
- |
- |
- |
- |
063 [1] 63 💬 |
58 |
E5501 40 mg 2 x 20-mg tablets, orally, fasted |
- |
- |
- |
- |
063 [1] 63 💬 |
59 |
E5501 40 mg 2 x 20-mg tablets, orally, with food |
- |
- |
- |
- |
063 [1] 63 💬 |
60 |
E5501 40mg 2 x 20-mg tablets, orally, fasted |
- |
- |
- |
- |
063 [1] 63 💬 |
61 |
Efgartigimod |
- |
- |
- |
- |
011 [3] 11, 35, 63 💬 |
62 |
Efgartigimod alfa |
Efgartigimod alfa |
[1] D11876 D11876 💬 |
- |
- |
014 [3] 14, 35, 63 💬 |
63 |
Eltrombopag |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
060 [5] 60, 63, 65, 284, 285 💬 |
64 |
Eltrombopag (revolade) |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
65 |
Eltrombopag combining rituximab |
Eltrombopag |
[2] D02994 D02994, D03978 D03978 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
66 |
Eltrombopag olamine |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
060 [2] 60, 63 💬 |
67 |
Eltrombopag olamine (sb-497115-gr) |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
68 |
Eltrombopag olamine, revolade, promacta |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
69 |
Eltrombopag oral tablets |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
063 [1] 63 💬 |
70 |
Fcm |
- |
- |
- |
- |
063 [2] 63, 222 💬 |
71 |
Gammaplex |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
72 |
Gammaplex, intravenous immunoglobulin |
- |
- |
- |
- |
063 [1] 63 💬 |
73 |
Glycyrrhetinic acid |
- |
- |
- |
- |
063 [1] 63 💬 |
74 |
Gma161 |
- |
- |
- |
- |
063 [1] 63 💬 |
75 |
Hbm9161 dose a |
- |
- |
- |
- |
063 [1] 63 💬 |
76 |
Hbm9161 dose b |
- |
- |
- |
- |
063 [1] 63 💬 |
77 |
Hetrombopag |
Hetrombopag |
- |
- |
- |
060 [2] 60, 63 💬 |
78 |
Hetrombopag olamine |
Hetrombopag |
- |
- |
- |
060 [2] 60, 63 💬 |
79 |
High dose dexamethasone pulses |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
063 [1] 63 💬 |
80 |
Huaiqihuang granule |
- |
- |
- |
- |
063 [1] 63 💬 |
81 |
Human immunoglobulin |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
82 |
Human immunoglobulin g |
Human immunoglobulin G |
- |
- |
- |
014 [4] 14, 50, 63, 65 💬 |
83 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 [9] 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
84 |
Human normal immunoglobulin (iv) |
Human immunoglobulin G |
- |
- |
- |
011 [4] 11, 14, 63, 65 💬 |
85 |
Human normal immunoglobulin for intravenous use |
Human immunoglobulin G |
- |
- |
- |
063 [2] 63, 65 💬 |
86 |
Human normal immunoglobulin for intrvenous use |
Human immunoglobulin G |
- |
- |
- |
063 [1] 63 💬 |
87 |
Human normal immunoglobulin g (igg > 98% purity) |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
88 |
Humax-cd38 |
- |
- |
- |
- |
028 [2] 28, 63 💬 |
89 |
I10e |
- |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
90 |
Ig vena |
- |
- |
- |
- |
050 [2] 50, 63 💬 |
91 |
Ig vena 100 ml vial |
- |
- |
- |
- |
063 [1] 63 💬 |
92 |
Ig vena 50 g/l solution for infusion 100 ml vial + infusion set |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
93 |
Igg next generation |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
94 |
Igiv3i grifols 10% |
- |
- |
- |
- |
063 [1] 63 💬 |
95 |
Ignextgen 10% |
- |
- |
- |
- |
063 [1] 63 💬 |
96 |
Immune globulin intravenous (human), 10% triple virally reduced solution |
- |
- |
- |
- |
063 [1] 63 💬 |
97 |
Immunglobulin |
- |
- |
- |
- |
063 [1] 63 💬 |
98 |
Immunoglobulin |
- |
- |
- |
- |
013 [3] 13, 14, 63 💬 |
99 |
Immunoglobulin g |
- |
- |
- |
- |
011 [7] 11, 13, 14, 49, 50, 63, 65 💬 |
100 |
Inactivated trivalent influenza vaccine |
- |
- |
- |
- |
063 [1] 63 💬 |
101 |
Interleukin 2 |
- |
- |
- |
- |
046 [9] 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
102 |
Ivig-l |
- |
- |
- |
- |
063 [1] 63 💬 |
103 |
Lansoprazole |
Lansoprazole |
[1] D00355 D00355 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [7] 63, 71, 85, 98, 166, 222, 299 💬 |
104 |
Lansoprazole, clarithromycin, amoxycillin |
Amoxicillin |
[5] D00229 D00229, D00276 D00276, D00355 D00355, D02925 D02925, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [1] 63 💬 |
105 |
Liv-gamma sn inj. |
- |
- |
- |
- |
063 [1] 63 💬 |
106 |
Mabthera |
- |
- |
- |
- |
011 [22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
107 |
Medical standard of care for itp |
- |
- |
- |
- |
063 [1] 63 💬 |
108 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
109 |
Metronidazole |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 [8] 46, 51, 63, 94, 95, 96, 97, 291 💬 |
110 |
Nanogam |
- |
- |
- |
- |
063 [1] 63 💬 |
111 |
Newgam |
- |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
112 |
Nplate |
- |
- |
- |
- |
063 [1] 63 💬 |
113 |
Nplate 500 microgramos polvo para solución inyectable |
- |
- |
- |
- |
063 [1] 63 💬 |
114 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
115 |
Octagam 10% |
- |
- |
- |
- |
050 [3] 50, 63, 65 💬 |
116 |
Octagam® 10% |
- |
- |
- |
- |
063 [1] 63 💬 |
117 |
Open label (avatrombopag tablets) |
Avatrombopag |
[1] D10306 D10306 💬 |
- |
- |
063 [1] 63 💬 |
118 |
Other: healthy controls |
- |
- |
- |
- |
063 [1] 63 💬 |
119 |
Other: rp% measurement by fcm as a diagnostic test for itp |
- |
- |
- |
- |
063 [1] 63 💬 |
120 |
Palmitate |
Palmitic Acid |
[1] D05341 D05341 💬 |
- |
- |
063 [1] 63 💬 |
121 |
Pf-06755347 intravenous |
- |
- |
- |
- |
063 [1] 63 💬 |
122 |
Pf-06755347 subcutaneous |
- |
- |
- |
- |
063 [1] 63 💬 |
123 |
Pg2 |
- |
- |
- |
- |
063 [1] 63 💬 |
124 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
125 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
126 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
127 |
Privigen® |
- |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
128 |
Promacta |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
129 |
Proteína recombinante estimulante de la megacariopoyesis |
- |
- |
- |
- |
063 [1] 63 💬 |
130 |
Prtx-100 (staphylococcal protein a) |
Bevifimod |
- |
- |
- |
063 [1] 63 💬 |
131 |
R788 |
- |
- |
- |
- |
046 [2] 46, 63 💬 |
132 |
Recombinant human thrombopoietin |
Recombinant Human Thrombopoietin |
- |
- |
- |
063 [1] 63 💬 |
133 |
Recombinant human thrombopoietin (rh-tpo) |
Recombinant Human Thrombopoietin |
- |
- |
- |
063 [1] 63 💬 |
134 |
Recombinant human thrombopoietin (rhtpo) |
Recombinant Human Thrombopoietin |
- |
- |
- |
063 [1] 63 💬 |
135 |
Relovade |
- |
- |
- |
- |
063 [1] 63 💬 |
136 |
Revolade |
- |
- |
- |
- |
060 [2] 60, 63 💬 |
137 |
Revolade 25 mg film-coated tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
138 |
Revolade 50 mg film-coated tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
139 |
Revolade, promacta |
- |
- |
- |
- |
063 [1] 63 💬 |
140 |
Rhtpo |
Recombinant Human Thrombopoietin |
- |
- |
- |
060 [2] 60, 63 💬 |
141 |
Rhtpo in combination with rituximab |
Recombinant Human Thrombopoietin |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
142 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
143 |
Rituximab [mabthera/rituxan] |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
046 [2] 46, 63 💬 |
144 |
Romiplostim |
Romiplostim |
[1] D08990 D08990 💬 |
MPL [1] MPL 💬 |
Cytokine-cytokine receptor interaction [2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway |
060 [4] 60, 63, 64, 65 💬 |
145 |
Romiplostin |
- |
- |
- |
- |
063 [1] 63 💬 |
146 |
Rozanolixizumab |
Rozanolixizumab |
- |
- |
- |
011 [3] 11, 14, 63 💬 |
147 |
Sb-497115 |
- |
- |
- |
- |
063 [1] 63 💬 |
148 |
Sb-497115-gr |
- |
- |
- |
- |
063 [1] 63 💬 |
149 |
Sb-497115-gr 12.5mg |
- |
- |
- |
- |
063 [1] 63 💬 |
150 |
Sb-497115-gr 25mg |
- |
- |
- |
- |
063 [1] 63 💬 |
151 |
Sb-497115-gr 50 mg |
- |
- |
- |
- |
063 [1] 63 💬 |
152 |
Sb497115 |
- |
- |
- |
- |
060 [2] 60, 63 💬 |
153 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
154 |
Sm101 |
- |
- |
- |
- |
049 [3] 49, 63, 66 💬 |
155 |
Sm101 20mg/ml |
- |
- |
- |
- |
063 [1] 63 💬 |
156 |
Sm101 5mg/ml |
- |
- |
- |
- |
063 [1] 63 💬 |
157 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
158 |
Staphylococcal protein a |
Bevifimod |
- |
- |
- |
063 [1] 63 💬 |
159 |
Steroids |
- |
- |
- |
- |
046 [7] 46, 50, 51, 63, 66, 96, 97 💬 |
160 |
Tak-079 |
- |
- |
- |
- |
011 [3] 11, 49, 63 💬 |
161 |
Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) |
Amoxicillin |
[7] D00229 D00229, D00276 D00276, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
063 [1] 63 💬 |
162 |
Thrombopoietin |
Thrombopoietin |
- |
- |
- |
047 [3] 47, 60, 63 💬 |
163 |
Tpo |
- |
- |
- |
- |
063 [1] 63 💬 |
164 |
Triple therapy |
- |
- |
- |
- |
063 [1] 63 💬 |
165 |
Tysabri |
- |
- |
- |
- |
013 [3] 13, 25, 63 💬 |
166 |
Ucb7665 |
- |
- |
- |
- |
011 [3] 11, 14, 63 💬 |
167 |
Vonoprazan |
Vonoprazan |
[1] D11784 D11784 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [2] 63, 98 💬 |
168 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |